课题基金 / 基金详情

ACTG 382--DMP 266 IN COMBINATION WITH NELFINAVIR IN HIV INFECTED CHILDREN

ACTG 382--DMP 266 IN COMBINATION WITH NELFINAVIR IN HIV INFECTED CHILDREN
ACTG 382--DMP 266 与奈非那韦联合治疗 HIV 感染儿童
批准号:
6219851
负责人:
Stuart E Starr
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Stuart E Starr的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ACTG 382 is a phase I/II, open-label study of a new antiretroviral drug combination (efavirenz plus nelfinavir) in children with HIV infection. This study evaluates this drug combination for its pharmacokinetics, safety, antiviral activity (as measured by changes in plasma HIV RNA level) and effects on immune reconstitution in children ages 3 months to 16 years of age. The treatment duration is 104 weeks. This multicenter study is nearing completion of accrual, and is currently open to accrual only for children in the youngest age cohort (3 months to 8 years of age). Preliminary data show favorable effects on suppression of viral load and acceptable tolerability for this drug combination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS
  • 批准号:
    6595455
  • 项目类别:
  • 资助金额:
    $18.67万
  • 财政年份:
    2002
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG377--ANTIRETROVIRAL REGIMENS W/ COMBOS OF PROTEASE INHIBITORS
  • 批准号:
    6306322
  • 项目类别:
  • 资助金额:
    $0.06万
  • 财政年份:
    1999
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG185--USE OF HIVIG FOR PREVENTION OF MATERNAL/FETAL TRANSMISSION OF HIV
  • 批准号:
    6116874
  • 项目类别:
  • 资助金额:
    $2.47万
  • 财政年份:
    1998
  • 负责人:
    Stuart E Starr
  • 依托单位:
ACTG 265--LIVE ATTENTUATED VARICELLA VACCINE IN HIV INFECTION CHILDREN
  • 批准号:
    6116899
  • 项目类别:
  • 资助金额:
    $2.47万
  • 财政年份:
    1998
  • 负责人:
    Stuart E Starr
  • 依托单位:
海外基金